CRL Competitors & Alternatives
Compare Charles River Laboratories with similar stocks in the same industry
Diagnostics & Research
CRL
Main Stock$181.23
Tradestie Score
62
Market Cap
$8.39B
Revenue Growth
0.0%
Analyst Upside
+17.1%
Top Competitors
37 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
COO
The Cooper Companies, Inc. Common Stock
|
$65.10
|
$13.53B | 55.1 | 60 | Compare |
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 65 | Compare |
|
RVTY
Revvity, Inc.
|
$99.05
|
$10.65B | 47.0 | 56 | Compare |
|
QGEN
QIAGEN N.V.
|
$36.47
|
$10.04B | 18.7 | 57 | Compare |
|
TECH
Bio-Techne Corp.
|
$56.48
|
$9.33B | 78.6 | 53 | Compare |
|
BIO
Bio-Rad Laboratories, Inc.Class A
|
$276.84
|
$8.06B | 47.4 | 51 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$125.51
|
$7.81B | - | 59 | Compare |
|
RDNT
RadNet, Inc. Common Stock
|
$53.73
|
$6.00B | - | 57 | Compare |
|
BLLN
BLLN
|
$99.30
|
$4.74B | 190.8 | 63 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$15.66
|
$4.60B | 37.7 | 54 | Compare |
More CRL Analysis
Data updated: Jun 22, 2026 | Industry: Diagnostics & Research (SIC 8731)
37 stocks in this industry